Literature DB >> 20956624

Nilotinib in a patient with postnecrotic liver cirrhosis related to imatinib.

Vito Spataro1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956624     DOI: 10.1200/JCO.2010.30.5359

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.

Authors:  Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal:  Drug Saf       Date:  2013-07       Impact factor: 5.606

2.  A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Authors:  Thenappan Thenappan; Ankush Goel; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Hannah J Zhang; Hidemi Kajimoto; Zhigang Hong; Jonathan Paul; Christian Wietholt; Jennifer Pogoriler; Lin Piao; Jalees Rehman; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

3.  Treatment with dasatinib for chronic myeloid leukemia following imatinib-induced hepatotoxicity.

Authors:  Lars Harbaum; Andreas Marx; Eray Goekkurt; Philippe Schafhausen; Djordje Atanackovic
Journal:  Int J Hematol       Date:  2013-11-22       Impact factor: 2.490

4.  Imatinib-induced liver cirrhosis in a patient with advanced gastrointestinal stroma tumor (GIST).

Authors:  Christoph Seidel; Martin Fenner; Florian Länger; Heike Bantel; Arnold Ganser; Viktor Grünwald
Journal:  BMC Cancer       Date:  2012-05-21       Impact factor: 4.430

Review 5.  European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia.

Authors:  J L Steegmann; M Baccarani; M Breccia; L F Casado; V García-Gutiérrez; A Hochhaus; D-W Kim; T D Kim; H J Khoury; P Le Coutre; J Mayer; D Milojkovic; K Porkka; D Rea; G Rosti; S Saussele; R Hehlmann; R E Clark
Journal:  Leukemia       Date:  2016-04-28       Impact factor: 11.528

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.